Analysts Set Agilent Technologies Inc (NYSE:A) Price Target at $85.75
Shares of Agilent Technologies Inc (NYSE:A) have been given a consensus recommendation of “Hold” by the twenty-one analysts that are currently covering the firm, Marketbeat reports. Thirteen investment analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $84.00.
A number of research firms recently weighed in on A. Bank of America lifted their price objective on shares of Agilent Technologies from $74.00 to $88.00 and gave the company a “neutral” rating in a research note on Friday, May 22nd. Cfra reduced their price target on shares of Agilent Technologies from $89.00 to $85.00 and set a “hold” rating for the company in a research report on Friday, May 22nd. Cowen boosted their price target on shares of Agilent Technologies from $80.00 to $95.00 and gave the company an “outperform” rating in a research report on Friday, May 22nd. UBS Group boosted their price target on shares of Agilent Technologies from $84.00 to $87.00 and gave the company a “neutral” rating in a research report on Friday, May 22nd. Finally, SVB Leerink boosted their price target on shares of Agilent Technologies from $90.00 to $95.00 and gave the company an “outperform” rating in a research report on Friday, May 22nd.
In other news, VP Rodney Gonsalves sold 4,566 shares of the company’s stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $85.30, for a total transaction of $389,479.80. Following the completion of the transaction, the vice president now directly owns 102,806 shares of the company’s stock, valued at $8,769,351.80. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Michael R. Mcmullen sold 13,603 shares of the company’s stock in a transaction dated Wednesday, April 29th. The shares were sold at an average price of $78.72, for a total transaction of $1,070,828.16. Following the transaction, the chief executive officer now directly owns 529,245 shares of the company’s stock, valued at $41,662,166.40. The disclosure for this sale can be found here. Insiders sold 64,426 shares of company stock valued at $5,300,943 over the last three months.
Shares of NYSE:A traded up $0.57 during mid-day trading on Friday, reaching $88.68. The company had a trading volume of 1,507,700 shares, compared to its average volume of 1,616,091. The company has a current ratio of 1.63, a quick ratio of 1.24 and a debt-to-equity ratio of 0.38. The firm has a market cap of $27.38 billion, a price-to-earnings ratio of 40.87, a PEG ratio of 2.85 and a beta of 1.12. The company’s 50-day moving average price is $86.77 and its 200-day moving average price is $81.72. Agilent Technologies has a one year low of $61.13 and a one year high of $93.04.
Agilent Technologies (NYSE:A) last released its quarterly earnings data on Thursday, May 21st. The medical research company reported $0.71 earnings per share for the quarter, beating analysts’ consensus estimates of $0.61 by $0.10. Agilent Technologies had a net margin of 13.04% and a return on equity of 20.76%. The business had revenue of $1.24 billion during the quarter, compared to analyst estimates of $1.20 billion. During the same period in the previous year, the business earned $0.71 EPS. Agilent Technologies’s revenue was up .2% compared to the same quarter last year. On average, research analysts anticipate that Agilent Technologies will post 3.11 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be paid a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.81%. The ex-dividend date is Monday, June 29th. Agilent Technologies’s dividend payout ratio is presently 23.15%.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.